1. Academic Validation
  2. A novel class of human 15-LOX-1 inhibitors based on 3-hydroxycoumarin

A novel class of human 15-LOX-1 inhibitors based on 3-hydroxycoumarin

  • Chem Biol Drug Des. 2018 Jun;91(6):1125-1132. doi: 10.1111/cbdd.13174.
Seyed Jamal Alavi 1 Hamid Sadeghian 2 3 Seyed Mohammad Seyedi 1 Alireza Salimi 1 Hossein Eshghi 1
Affiliations

Affiliations

  • 1 Department of Chemistry, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran.
  • 2 Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • 3 Department of Laboratory Sciences, School of Paramedical Sciences, Mashhad University of Medical Sciences, Mashhad, Iran.
Abstract

Inflammations, sensitivities, and some cancers in mammals are intimately linked to the activity of lipo-oxygenase enzymes. Owing to the importance of these enzymes, mechanistic studies, product analysis, and synthesis of inhibitors have expanded. In this study, a series of hydroxycoumarins, methoxy-3-hydroxy Coumarins, and 7-alkoxy-3-hydroxy Coumarins were synthesized and evaluated as potential inhibitors of human 15-LOX-1. Among the synthetic Coumarins, 7-methoxy-3-hydroxycoumarin derivative demonstrated potent inhibitory activity and the compound, 5f, showed the best result. Radical scavenging assessment, IC50 , HNMR, and DPPH bleaching results indicate that the electronic properties are the major factors for the lipo-oxygenase inhibition potency of the synthetic Coumarins. Based on the theoretical studies, it was suggested that the mesomeric effect of the substituent at the seventh position of the benzene ring is one of the major factors in the stability of the oxy-radical intermediate.

Keywords

DMAB; DPPH; MBTH; bond energy dissociation; inhibitory mechanism.

Figures
Products